Market capitalization | $195.12m |
Enterprise Value | $209.18m |
P/E (TTM) P/E ratio | 17.22 |
EV/FCF (TTM) EV/FCF | 9.13 |
EV/Sales (TTM) EV/Sales | 4.75 |
P/S ratio (TTM) P/S ratio | 4.43 |
P/B ratio (TTM) P/B ratio | 0.69 |
Revenue growth (TTM) Revenue growth | 16.09% |
Revenue (TTM) Revenue | $44.05m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
1 Analyst has issued a forecast Swk Holdings Corp:
1 Analyst has issued a forecast Swk Holdings Corp:
Sep '24 |
+/-
%
|
||
Revenue | 44 44 |
16%
16%
|
|
Gross Profit | 40 40 |
29%
29%
|
|
EBITDA | 34 34 |
53%
53%
|
EBIT (Operating Income) EBIT | 19 19 |
19%
19%
|
Net Profit | 12 12 |
27%
27%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
SWK Holdings Corporation, a specialized finance company, focuses on the healthcare sector. It intends to provide customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Head office | United States |
CEO | Joe Staggs |
Employees | 23 |
Founded | 1996 |
Website | www.swkhold.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.